Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants

Pediatrics

Volumn 123, Issue 4, 2009, Pages 1132-1141

  Ambalavanan, Namasivayam ^a,h   Carlo, Waldemar A ^a   D'Angio, Carl T ^b   McDonald, Scott A ^c   Das, Abhik ^c   Schendel, Diana ^d   Thorsen, Poul ^e,f   Higgins, Rosemary D ^g  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c RTI INTERNATIONAL   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^e AARHUS UNIVERSITY   (Denmark)

^f EMORY UNIVERSITY   (United States)

^g Center for Developmental Biology and Perinatal Medicine   (United States)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Infant; Logistic models; Predictive value of tests; Premature

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN;

ADAPTIVE IMMUNITY; ARTICLE; BIRTH; BLOOD SAMPLING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEATH; ENZYME ACTIVATION; ENZYME REGULATION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; LUNG DYSPLASIA; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SURVIVOR; T LYMPHOCYTE; BLOOD; CELLULAR IMMUNITY; CHORIOAMNIONITIS; IMMUNOLOGY; INNATE IMMUNITY; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; PREGNANCY; STATISTICAL MODEL;

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREGNANCY;

EID: 65349120594     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0526     Document Type: Article

References (39)

1. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196(2):147.e1-147.e8
2. Ambalavanan N, Carlo WA. Bronchopulmonary dysplasia: new insights. Clin Perinatol. 2004;31(3):613-628 (Pubitemid 39119488)
3. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14(6):523-535 (Pubitemid 37296025)
4. Belperio JA, Keane MP, Lynch JP III, Strieter RM. The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin Respir Crit Care Med. 2006;27(4):350-364 (Pubitemid 44272604)
5. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest. 2002;109(6):699-705 (Pubitemid 34263143)
6. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ. Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res. 1996;40(2):250-256 (Pubitemid 26249677)
7. Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37(2):137-148 (Pubitemid 38120984)
8. Vento G, Capoluongo E, Matassa PG, et al. Serum levels of seven cytokines in premature ventilated newborns: correlations with old and new forms of bronchopulmonary dysplasia. Intensive Care Med. 2006;32(5):723-730
9. Viscardi RM, Muhumuza CK, Rodriguez A, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res. 2004;55(6):1009-1017 (Pubitemid 38661794)
10. Skogstrand K, Thorsen P, Nørgaard-Pedersen P, et al. Simultaneous determination of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay xMAP technology. Clin Chem. 2005;51(10):1854-1866 (Pubitemid 41368176)
11. Skogstrand K, Ekelund CK, Thorsen P, et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods. 2008;336(1):78-84
12. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901-1906 (Pubitemid 46071232)
13. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev. 1996;9(4):532-562 (Pubitemid 26366537)
14. Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate. 2003;84(4):297-303 (Pubitemid 37356743)
15. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095-2147 (Pubitemid 26086851)
16. Ley K, Smith E, Stark MA. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res. 2006;34(3):229-242 (Pubitemid 44195938)
17. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6(11):1133-1141 (Pubitemid 41541791)
18. Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood. 2003;101(7):2620-2627 (Pubitemid 36857622)
19. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L600-L607
20. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Sasaki H. Interferon-γ: a key contributor to hyperoxia-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol. 2004;287(5):L1042-L1047
21. Wang Z, Zheng T, Zhu Z, et al. Interferon γ induction of pulmonary emphysema in the adult murine lung. J Exp Med. 2000;192(11):1587-1600
22. Jiang D, Liang J, Hodge J, et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest. 2004;114(2):291-299 (Pubitemid 39071634)
23. Howard MC, Miyajima A, Coffmann R. T-cell-derived cytokines and their receptors. In: Paul WE, ed. Fundamental Immunology. 3rd ed. New York, NY: Raven Press; 1993:763-800
24. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3(9):745-756 (Pubitemid 41070815)
25. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 2003;284(4):L566-L577 (Pubitemid 36343304)
26. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):1-6 (Pubitemid 40116529)
27. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001;22(2):83-87 (Pubitemid 32667526)
28. Song A, Nikolcheva T, Krensky AM. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol Rev. 2000;177:236-245
29. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leukoc Biol. 2002;71(2):173-183
30. + T cells into the interstitium of the normal lung. J Clin Invest. 2005;115(12):3473-3483 (Pubitemid 43121835)
31. Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A. 1999;96(8):4581-4585 (Pubitemid 29190379)
32. Nickel RG, Casolaro V, Wahn U, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol. 2000;164(3):1612-1616 (Pubitemid 30067281)
33. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med. 2002;30(1 suppl):S58-S63 (Pubitemid 34131163)
34. Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med. 1997;155(4):1469-1473 (Pubitemid 27172800)
35. Garingo A, Tesoriero L, Cayabyab R, et al. Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr Res. 2007;61(2):197-202 (Pubitemid 46146878)
36. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther. 2006;8(suppl 2):S2 (Pubitemid 44363227)
37. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;(8 suppl 2):S3 (Pubitemid 44363228)
38. Smolen JS, Maini RN. Interleukin-6: a new therapeutic target. Arthritis Res Ther. 2006;8(suppl 2):S5
39. Yamagata T, Ichinose M. Agents against cytokine synthesis or receptors. Eur J Pharmacol. 2006;533(1-3):289-301 (Pubitemid 43340020)